Rendering
Component: (Network and Table) |
---|
Network | 2309301 - Disclosure - Income Taxes (Tables) (http://www.aeriepharma.com/role/IncomeTaxesTables) |
Table | (Implied) |
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis] | 0001337553 (http://www.sec.gov/CIK) |
Income Tax Disclosure [Abstract] | Period [Axis] |
---|
2016-01-01 - 2016-12-31 |
---|
Income Tax Disclosure [Abstract] | |
Components of Provision for Income Taxes | The provision for income taxes is based on net loss before income taxes as follows: | | | | | | | | | | | | | | DECEMBER 31, | (in thousands) | 2016 | | 2015 | | 2014 | Net loss before income taxes: | | | | | | United States | $ | (88,123 | ) | | $ | (59,211 | ) | | $ | (48,133 | ) | Other | (10,743 | ) | | (15,013 | ) | | — |
| Net loss before income taxes | $ | (98,866 | ) | | $ | (74,224 | ) | | $ | (48,133 | ) | | | | | | | The components of the provision for income taxes are as follows:
| | | | DECEMBER 31, | (dollars in thousands) | 2016 | | 2015 | | 2014 | Provision for income taxes: | | | | | | Current: | | | | | | United States | $ | 193 |
| | $ | 139 |
| | $ | — |
| Other | — |
| | — |
| | — |
| Total | $ | 193 |
| | $ | 139 |
| | $ | — |
| Deferred: | | | | | | United States | $ | — |
| | $ | — |
| | $ | — |
| Other | — |
| | — |
| | — |
| Total | — |
| | — |
| | — |
| Provision for income taxes | $ | 193 |
| | $ | 139 |
| | $ | — |
| Effective tax rate | (0.19 | )% | | (0.19 | )% | | — | % |
|
Summary of Significant Components of Company's Net Deferred Income Tax Assets | Significant components of the Company’s net deferred income tax assets as of December 31, 2016 and 2015 consist of the following: | | | | | | | | | | DECEMBER 31, | (in thousands) | 2016 | | 2015 | Net deferred tax assets: | | | | Net operating loss carry-forwards | $ | 39,188 |
| | $ | 6,335 |
| Share based compensation | 11,845 |
| | 7,231 |
| U.S. tax credit carry-forwards | 4,566 |
| | 3,823 |
| Other assets | 1,998 |
| | 1,488 |
| Other liabilities | (860 | ) | | (696 | ) | Valuation allowance | (56,737 | ) | | (18,181 | ) | Total net deferred income taxes | $ | — |
| | $ | — |
|
|
Reconciliation of U.S. Statutory Rate and Effective Tax Rate | A reconciliation of the statutory tax rates and the effective tax rates for the years ended December 31, 2016, 2015 and 2014 is as follows: | | | | | | | | | | | DECEMBER 31, | | 2016 | | 2015 | | 2014 | U.S. federal tax rate | 35.00 | % | | 35.00 | % | | 35.00 | % | State income taxes, net of federal benefit | 5.34 | % | | (0.90 | )% | | 6.13 | % | Taxable gain resulting from IP Assignment | — | % | | (75.31 | )% | | — | % | Non-taxable foreign loss | (2.69 | )% | | (6.98 | )% | | — | % | Tax deferral from IP Assignment | (0.19 | )% | | 3.56 | % | | — | % | Other | (1.45 | )% | | 0.02 | % | | (0.04 | )% | Valuation allowance | (36.20 | )% | | 44.42 | % | | (41.09 | )% | Effective tax rate | (0.19 | )% | | (0.19 | )% | | — | % |
|